Try our Advanced Search for more refined results

November 07, 2014

Endo Pharmaceuticals Inc. et al. v. Amneal Pharmaceuticals LLC, et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 07, 2016

    Teva, Amneal Lose Opana ER Patent Fight Against Endo

    A Delaware federal judge on Friday upheld the validity of an Endo Pharmaceuticals Inc. patent for its opioid painkiller Opana ER, shooting down arguments from Amneal Pharmaceuticals LLC and Teva Pharmaceuticals USA Inc. that it was invalid and that Teva had express permission to use the active ingredient it covered.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login